Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alastair Burt

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Gut|August 3, 2010
Enhanced liver fibrosis test can predict clinical outcomes in patients with chronic liver diseaseJulie Parkes, Paul Roderick, Scott Harris, et al.
The American Journal of Gastroenterology|October 12, 2016
Age as a Confounding Factor for the Accurate Non-Invasive Diagnosis of Advanced NAFLD FibrosisStuart McPherson, Tim Hardy, Jean-Francois Dufour, et al.
Nature Communications|June 14, 2017
Cellular senescence drives age-dependent hepatic steatosisMikolaj Ogrodnik, Satomi Miwa, Tamar Tchkonia, et al.
The American Journal of Gastroenterology|May 27, 2020
Presence of Serum Antinuclear Antibodies Does Not Impact Long-Term Outcomes in Nonalcoholic Fatty Liver DiseaseRamy Younes, Olivier Govaere, Salvatore Petta, et al.
Journal of Hepatology|October 10, 2025
Consensus position statements for the standardized application of histological grading and staging systems in MASH clinical trialsCarolin Lackner, Annette S H Gouw, Venancio Avancini Ferreira Alves, et al.
Journal of Hepatology|June 6, 2021
Long-term outcomes and predictive ability of non-invasive scoring systems in patients with non-alcoholic fatty liver diseaseRamy Younes, Gian Paolo Caviglia, Olivier Govaere, et al.
Gut|February 5, 2021
Caucasian lean subjects with non-alcoholic fatty liver disease share long-term prognosis of non-lean: time for reappraisal of BMI-driven approach?Ramy Younes, Olivier Govaere, Salvatore Petta, et al.
BMJ Open Gastroenterology|April 22, 2022
COVID-19 and liver cancer: lost patients and larger tumoursDaniel Geh, Robyn Watson, Gourab Sen, et al.
Contemporary Clinical Trials|October 12, 2020
The European NAFLD Registry: A real-world longitudinal cohort study of nonalcoholic fatty liver diseaseTimothy Hardy, Kristy Wonders, Ramy Younes, et al.
Gut|January 10, 2024
Serum ferritin levels can predict long-term outcomes in patients with metabolic dysfunction-associated steatotic liver diseaseAngelo Armandi, Tiziana Sanavia, Ramy Younes, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Gut|August 3, 2010
Enhanced liver fibrosis test can predict clinical outcomes in patients with chronic liver diseaseJulie Parkes, Paul Roderick, Scott Harris, et al.
The American Journal of Gastroenterology|October 12, 2016
Age as a Confounding Factor for the Accurate Non-Invasive Diagnosis of Advanced NAFLD FibrosisStuart McPherson, Tim Hardy, Jean-Francois Dufour, et al.
Nature Communications|June 14, 2017
Cellular senescence drives age-dependent hepatic steatosisMikolaj Ogrodnik, Satomi Miwa, Tamar Tchkonia, et al.
The American Journal of Gastroenterology|May 27, 2020
Presence of Serum Antinuclear Antibodies Does Not Impact Long-Term Outcomes in Nonalcoholic Fatty Liver DiseaseRamy Younes, Olivier Govaere, Salvatore Petta, et al.
Journal of Hepatology|October 10, 2025
Consensus position statements for the standardized application of histological grading and staging systems in MASH clinical trialsCarolin Lackner, Annette S H Gouw, Venancio Avancini Ferreira Alves, et al.
Journal of Hepatology|June 6, 2021
Long-term outcomes and predictive ability of non-invasive scoring systems in patients with non-alcoholic fatty liver diseaseRamy Younes, Gian Paolo Caviglia, Olivier Govaere, et al.
Gut|February 5, 2021
Caucasian lean subjects with non-alcoholic fatty liver disease share long-term prognosis of non-lean: time for reappraisal of BMI-driven approach?Ramy Younes, Olivier Govaere, Salvatore Petta, et al.
BMJ Open Gastroenterology|April 22, 2022
COVID-19 and liver cancer: lost patients and larger tumoursDaniel Geh, Robyn Watson, Gourab Sen, et al.
Contemporary Clinical Trials|October 12, 2020
The European NAFLD Registry: A real-world longitudinal cohort study of nonalcoholic fatty liver diseaseTimothy Hardy, Kristy Wonders, Ramy Younes, et al.
Gut|January 10, 2024
Serum ferritin levels can predict long-term outcomes in patients with metabolic dysfunction-associated steatotic liver diseaseAngelo Armandi, Tiziana Sanavia, Ramy Younes, et al.
Pageof 3